Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers
M. Tarabichi, A. Antoniou, S. Le Pennec, D. Gacquer, N. de Saint Aubain, L. Craciun, T. Cielen, I. Laios, D. Larsimont, G. Andry, J. E. Dumont, C. Maenhaut, V. Detours
Abstract
Textbooks suggest that cancers are compact balls with an inner core and an invasive front in contact with non-cancerous cells, and that tumor growth is driven by tumor cell proliferation subsequent to oncogenic genome mutations. We reconstructed at histological scale the 3D volume occupied by tumor cells in two regions of a BRAFV600E-mutated papillary thyroid carcinoma (PTC) with low tumor purity, as determined by sequencing, but initially considered high purity during pathology review. In contrast with a compact ball, tumor cells formed a sparse mesh deeply embedded within the stroma. The concepts of inner core and invasive front broke down in this morphology: all tumor cells were within short distance from the stroma. The fibrous stroma was highly cellular and proliferative, a result confirmed in an independent series. This case was not unique: 3.5% of The Cancer Genome Atlas PTCs had purities <25%, 27% were below the 60% purity inclusion criterion. Moreover, the presence of BRAFV600E was associated with extensive fibrosis, high stromal activation, and dedifferentiation. Thus, non-tumor cells make most of the tumor mass and contribute to its expansion in a significant fraction of BRAFV600E PTCs. Therapeutics targeting the tumor-stroma crosstalk could be beneficial in this context.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
H. Lasolle, A. A. Schiavo, … M. Romitti·bioRxiv·Mar 30, 2023
- Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers
Adrien Tourneur, Joel Rodrigues Vitória, … Vincent Detours·Molecular OncologyPeer-reviewed·Aug 11, 2026
- BRAFV600E expression in thyrocytes causes recruitment of immunosuppressive STABILIN-1 macrophages
C. Spourquet, O. Delcorte, … C. E. Pierreux·CancersPeer-reviewed·Sep 26, 2022
- Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells
Jerry H. Houl, Rozita Bagheri‐Yarmand, … Marie-Claude C. Hofmann·Molecular Cancer TherapeuticsPeer-reviewed·Dec 2, 2025
- PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors.
M. A. Roelli, D. Ruffieux-Daidie, … R.-P. Charles·bioRxiv·Jul 18, 2017
- Heterogeneous pro-inflammatory response to BRAFV600E-induced thyroid tumor development
Sima Kumari, Carmen Moccia, … Mikael Nilsson·bioRxiv·Mar 29, 2026